Condition
Esophagogastric Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Esophagogastric Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Canada (1)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Mesothelin-targeted CAR T-cell therapy for esophagogastric cancer
This study is testing a new treatment that uses modified immune cells to target and attack tumors in people with advanced esophagogastric cancer.
-
Understanding the molecular characteristics of gastroesophageal adenocarcinoma
This study is trying to learn more about the biology of gastroesophageal adenocarcinoma to help doctors choose better treatments for patients with both localized and advanced cancer.
Related topics
Quick answers
How many Esophagogastric Adenocarcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.